Ads
related to: issues with inspire sleep devicebodywinning.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...
Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. ... sleep apnea can negatively affect quality of sleep. This may lead to problems with memory ...
Called an Inspire implant, this device sends gentle pulses overnight that move the tongue forward, opening the airway. The implant can help considerably, though researchers are working to improve it.
The implant may be configured to best accommodate the patient's comfort and sleeping habits (e.g., set a delay based on sleep latency). The hypoglossal nerve stimulator implantable pulse generator battery life typically lasts 8–12 years, after which the implantable pulse generator may be safely replaced with another surgery.
In April 2014, the U.S. Food and Drug Administration granted pre-market approval for use of an upper airway stimulation system in people who cannot use a continuous positive airway pressure device. The Inspire Upper Airway Stimulation system is a hypoglossal nerve stimulator that senses respiration and applies mild electrical stimulation during ...
Sleep surgery is a surgery performed to treat sleep disordered breathing. Sleep disordered breathing is a spectrum of disorders that includes snoring, upper airway resistance syndrome, and obstructive sleep apnea. These surgeries are performed by surgeons trained in otolaryngology, oral maxillofacial surgery, and craniofacial surgery.